Indaptus Therapeutics Inc
Change company Symbol lookup
Select an option...
INDP Indaptus Therapeutics Inc
FUSN Fusion Pharmaceuticals Inc
RDUS Schnitzer Steel Industries Inc
ALEC Alector Inc
LZM Lifezone Metals Ltd
LMRMF Lomiko Metals Inc
SOXL Direxion Daily Semiconductor Bull 3X Shares
OXSQ Oxford Square Capital Corp
BAER Bridger Aerospace Group Holdings Inc
CMRA Comera Life Sciences Holdings Inc
Go

Health Care : Biotechnology |
Company profile

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The Company is focused on enhancing and expanding curative cancer immunotherapy for patients with unresectable or metastatic solid tumors and lymphomas. It designs its approach by targeting specific tumor or viral antigens. Its lead candidate, Decoy20, through pre-clinical development. Its platform is based on the hypothesis that require anti-tumor immunotherapy to activate both innate and adaptive cellular immunity in both tumors and immune organs. Its approach uses multi-targeted package of bacterial pathogen-associated molecular patterns (PAMPs), in the form of attenuated and killed, intact but non-pathogenic bacteria delivered intravenously. Its intravenous therapeutic candidates target the liver, spleen, and leaky vasculature of tumors, producing immune activation in an immune organ, as well as a common site for primary and metastatic cancer and hepatitis B virus (HBV) infection.

Postmarket

Last Trade
Delayed
$2.53
0.04 (1.61%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$2.49
Day's Change
-0.22 (-8.12%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
2.85
Day's Low
2.40
Volume
(Light)
Volume:
29,223

10-day average volume:
40,136
29,223

General Motors Co. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

4:58 pm ET May 22, 2023 (MarketWatch)
Print

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of General Motors Co. (GM) inched 0.61% higher to $32.86 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.02% to 4,192.63 and the Dow Jones Industrial Average falling 0.42% to 33,286.58.

General Motors Co. closed $10.77 below its 52-week high ($43.63), which the company reached on February 16th.

The stock underperformed when compared to some of its competitors Monday, as Tesla Inc. (TSLA) rose 4.85% to $188.87.

Trading volume (8.8 M) remained 5.8 million below its 50-day average volume of 14.6 M.

Data source: Dow Jones Market Data, FactSet. Data compiled May 22, 2023.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

	

(END) Dow Jones Newswires

May 22, 2023 16:58 ET (20:58 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.